BACKGROUND: The diagnosis of prostate cancer (PCa) is currently based on serum PSA
testing and/or abnormal digital rectal examination and histopathologic evaluation of prostate …

Prostate cancer is a heterogeneous disease with a variable natural history. Therefore,
optimal management remains challenging. While many men with newly diagnosed prostate …

Purpose: Multiparametric magnetic resonance imaging has an emerging role in prostate
cancer diagnostics. In addition, clinical information is a reliable predictor of significant …

Background Up to a third of patients with localized prostate cancer have unilateral disease
that may be suitable for partial treatment with hemiablation. Objective To evaluate the ability …

These guidelines cover a wide range of topics from prostate cancer epidemiology to
palliative care. Questions arising in daily clinical practice have been extracted and …

Purpose Following a prostate cancer diagnosis, patients are faced with a multitude of care
options, the advisability of which is influenced by patient factors and by cancer severity or …

Background: Although the prognosis of localised prostate cancer is good, the negative
effects of prostate cancer treatment often impair patient quality of life. A growing number of …

Objectives To assess the value of risk‐stratification based on magnetic resonance imaging
(MRI) and prostate‐specific antigen density (PSA‐D) in reducing unnecessary biopsies …

Context The incidence of low-risk prostate cancer (PCa) has increased as a consequence of
prostate-specific antigen testing. Objective In this collaborative review article, we examine …

Background Multiparametric magnetic resonance imaging (mpMRI)/ultrasound fusion biopsy
(targeted biopsy or TB) may improve detection of high-grade cancers when compared to …